tiprankstipranks
Company Announcements

Boundless Bio Adjusts Stock Options to Incentivize Key Staff

Don't Miss our Black Friday Offers:

Boundless Bio Inc. (BOLD) has shared an update.

Boundless Bio, Inc. has initiated a stock option repricing for select employees and executive officers to $3.56 per share, aligning with the company’s closing stock price on August 19, 2024. This move aims to retain and incentivize key personnel while avoiding additional equity grants and cash expenses. Repriced options are subject to service conditions until a designated “Premium End Date,” with specific terms for early exercise or termination. Notably, top executives have had a significant number of their options adjusted, maintaining the original terms except for the new, lowered exercise price.

For an in-depth examination of BOLD stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBoundless Bio’s Q3 2024: Advancing Cancer Therapies
TheFlyBoundless Bio reports Q3 EPS (74c), consensus (75c)
TipRanks Auto-Generated NewsdeskBoundless Bio Appoints New CFO Following Departure
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App